Skip to main content

Staurosporine

ALX-380-014

112 citations

  • ALX-380-014-M001   —   1 mg
    $347.00
  • ALX-380-014-M005   —   5 mg
    $825.00
  • ALX-380-014-C250   —   250 µg
    $150.00
  • Model apoptosis inducer
  • Potent cell-permeable inhibitor of protein kinases
  • Highly cited

Staurosporine is the reference agent for apoptosis induction (1µM in CHO cells). Staurosporine binds to the ATP binding site and inhibits a variety of protein kinases including protein kinase C (PKC), CDK1/cyclin B (IC50~5nM), CDK2/cyclin A (IC50=7nM), CDK4/cyclin D (IC50=3-10µM), CDK5/p25 (IC50=4nM), GSK-3β (IC50=15nM), and Pim-1 kinase (IC50=10nM). Staurosporine does not inhibit PKC-ζ. Staurosporine also inhibits topoisomerase II directly by blocking transfer of phosphodiester bonds from DNA to active site tyrosine. Other than apoptosis and cytotoxicity, some of the biological effects of staurosporine include regulation of eNOS gene expression and relaxation of smooth mucles.

Shipping: Available products typically ship within 24/48h, via priority shipping.

Do you need support? Contact Customer Service or Technical Support.

Online Account
Access or Create Your Account


Regulatory Status

RUO – Research Use Only